SUTRO BIOPHARMA, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.88 USD | -2.70% |
|
-1.87% | -32.87% |
| Jun. 03 | Vgxi Inc. Announces Strategic Partnership with Sutro Biopharma Inc. to Support Growing Clinical Pipeline | CI |
| May. 13 | Sutro Biopharma Q1 Loss Widens, Revenue Rises | MT |
Chart calendar Sutro Biopharma, Inc.
783adaba93dad16076cc4629a490f46.vhnGStQXjVV4G-L9XODbnAzLtndfeadFGhV9C5rnMvc.5FTwHplR7mUefYbEEoaB5U-OzAAmTP13YnAybOrQdbmPS7Eztn7-BDB_0g~ccb3854bc0454279dea63145958a9b13
Upcoming events on Sutro Biopharma, Inc.
Past events on Sutro Biopharma, Inc.
| 2024-06-06 12:00 pm | Annual General Meeting |
| 2024-06-06 08:00 am | Jefferies Global Healthcare Conference |
| 2024-05-14 10:30 am | Citizens JMP Life Sciences Conference |
| 2024-05-13 04:30 pm | Q1 2024 Earnings Release |
| 2024-03-25 04:30 pm | Q4 2023 Earnings Release |
| 2024-03-11 | Barclays Global Healthcare Conference |
| 2024-03-05 10:30 am | TD Cowen Health Care Conference |
| 2024-02-13 02:00 pm | Oppenheimer Healthcare Life Sciences Conference |
| 2024-01-04 04:30 pm | Business Update Call |
| 2023-12-11 09:00 pm | American Society of Hematology Meeting |
| 2023-12-06 02:30 pm | JMP Securities Hematology and Oncology Summit |
| 2023-11-28 08:30 am | Piper Sandler Healthcare Conference |
| 2023-11-15 03:00 am | Jefferies London Healthcare Conference |
| 2023-11-13 04:30 pm | Q3 2023 Earnings Release |
| 2023-10-22 04:15 am | European Society for Medical Oncology Congress |
| 2023-10-18 05:00 pm | World ADC Conference |
| 2023-10-18 03:00 pm | World ADC Conference |
| 2023-10-17 09:00 pm | World ADC Conference - Poster |
| 2023-10-17 08:30 pm | World ADC Conference |
| 2023-10-17 05:00 pm | World ADC Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 42,7 41,4 3.28% | 42,7 42,7 0.14% | 61,9 61,7 0.27% | 67,8 68,4 -0.87% | 154 52,3 193.78% | 56,2 |
|
EBITDA Million USD | Released Forecast Spread | -50,7 -51,7 1.91% | 0,00 0,00 - | -93,7 -97,0 3.42% | -123 -125 1.4% | 0,00 0,00 - | -234 |
|
EBIT Million USD | Released Forecast Spread | -55,5 -56,7 2.17% | -71,1 -64,5 -10.25% | -98,5 -96,1 -2.55% | -129 -120 -7.21% | -89,3 -183 51.14% | -232 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -55,7 -57,5 3.09% | -32,1 6,24 -614.77% | -106 -102 -3.96% | -117 -123 4.88% | -88,6 -184 51.92% | -236 |
|
Net income Million USD | Released Forecast Spread | -55,7 -57,1 2.34% | -32,1 5,72 -661.54% | -106 -99,9 -5.66% | -119 -124 4.14% | -107 -186 42.48% | -237 |
|
EPS USD | Released Forecast Spread | -2,43 -2,48 2.12% | -0,99 0,08 -1318.46% | -2,29 -2,16 -5.8% | -2,35 -2,51 6.42% | -1,78 -3,09 42.31% | -3,43 |
| Announcement Date | 16/03/20 | 18/03/21 | 28/02/22 | 30/03/23 | 25/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 5,90 10,5 -43.62% | 28,1 13,2 113.63% | 25,1 35,8 -29.68% | 8,63 14,5 -40.39% | 12,7 12,1 4.84% | 10,4 12,5 -16.81% | 16,9 13,0 30.14% | 114 13,2 758.64% | 13,0 12,1 7.74% | 21,1 | 10,1 | 11,1 | 7,46 | 7,54 |
|
EBIT Million USD | Released Forecast Spread | -39,1 -36,4 -7.6% | -19,4 -20,8 6.75% | -21,2 -13,6 -55.51% | -49,2 -33,7 -45.89% | -42,2 -47,1 10.3% | -46,2 -44,5 -3.68% | -44,0 -44,5 1.03% | 43,2 -49,5 187.1% | -56,6 -57,4 1.35% | -50,1 | -62,2 | -63,8 | -70,2 | -72,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -39,1 -35,4 -10.48% | -23,5 -18,2 -29.06% | -19,5 -13,4 -45.24% | -34,6 -34,3 -0.85% | -49,7 -46,9 -5.85% | -38,4 -44,8 14.25% | -47,4 -43,7 -8.47% | 46,9 -49,7 194.25% | -58,2 -58,4 0.4% | -50,7 | -63,9 | -65,8 | -72,0 | -74,1 |
|
Net income Million USD | Released Forecast Spread | -39,1 -36,4 -7.46% | -26,0 -21,6 -20.59% | -19,5 -13,4 -45.24% | -34,6 -34,3 -0.85% | -50,1 -46,9 -6.69% | -38,5 -44,8 13.92% | -49,3 -43,7 -12.68% | 31,1 -49,7 162.47% | -58,2 -58,6 0.73% | -51,4 | -63,5 | -65,8 | -72,0 | -74,1 |
|
EPS USD | Released Forecast Spread | -0,84 -0,76 -10.89% | -0,55 -0,43 -28.28% | -0,37 -0,29 -28.14% | -0,61 -0,62 1.81% | -0,85 -0,81 -4.75% | -0,64 -0,75 14.34% | -0,81 -0,74 -10.05% | 0,52 -0,81 164.3% | -0,95 -0,93 -2.17% | -0,78 | -0,90 | -0,92 | -0,93 | -0,91 |
| Announcement Date | 09/05/22 | 08/08/22 | 08/11/22 | 30/03/23 | 15/05/23 | 10/08/23 | 13/11/23 | 25/03/24 | 13/05/24 | - | - | - | - | - |
More events
Past sector events for Sutro Biopharma, Inc.
| 2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- STRO Stock
- Calendar Sutro Biopharma, Inc.
